The treatment of tension-type headache. Guidelines of the German migraine- and headache society;Die behandlung des kopfschmerzes vom spannungstyp. Therapieempfehlungen der Deutschen migrane- und kopfschmerzgesellschaft

Nervenheilkunde

Volumn 17, Issue 2, 1998, Pages 91-100

  Pfaffenrath, V ^a,f   Brune, K ^b   Diener, H C ^c   Gerber, W D ^d   Gobel H ^e  

^a Neurologische Fachpraxis   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f Neurologe   (Germany)

Author keywords

Acute treatment; Definition; Episodic and chronic tension type headache; Non pharmacological treatment measures; Pathophysiology; Prophylaxis

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; AMITRIPTYLINOXIDE; BACLOFEN; BENZODIAZEPINE; CITALOPRAM; CLOMIPRAMINE; CYCLOBENZAPRINE; CYPROHEPTADINE; DOPAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; IBUPROFEN; MAPROTILINE; MIANSERIN; MOCLOBEMIDE; MORPHINE; NAPROXEN; PARACETAMOL; PAROXETINE; PIZOTIFEN; SULPIRIDE; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; TIZANIDINE; TRANYLCYPROMINE PLUS TRIFLUOPERAZINE; VALPROIC ACID;

ACUPRESSURE; ACUPUNCTURE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG CONTRAINDICATION; DRUG INDUCED DISEASE; FEEDBACK SYSTEM; HUMAN; MIGRAINE; PATHOPHYSIOLOGY; PHYSIOTHERAPY; PREVALENCE; PROPHYLAXIS; RELAXATION TRAINING; REVIEW; TENSION HEADACHE; TRANSCUTANEOUS NERVE STIMULATION;

EID: 0031869352     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Soyka D, Diener HC, Pfaffenrath V et al. Behandlung des Spannungskopfschmerzes - Empfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft. Münch Med Wschr 1990; 132: 353-6.
2. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 Supp. 7: 1-96.
3. Schoenen J, Gerard P, De Pasqua V et al. Multiple clinical and paraclinical analyses of chronic tension-type headache associated or unassociated with disorder of pericranial muscles. Cephalalgia 1991; 11: 135-9.
4. Pfaffenrath V, Isler HR. Evaluation of the nosology of chronic tension-type headache. Cephalalgia 1993; 13 Suppl. 12: 60-62.
5. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol 1991; 44: 1147-57.
6. Pryse-Philips W, Findlay H, Tugwell P et al. A Canadian Population Survey on the Clinical, Epidemiologic and Societal Impact of Migraine and Tension-Type Headache. Can J Neurol Sci 1992; 19: 333-9.
7. Göbel H, Petersen-Braun M, Soyka D. The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia 1994; 14: 97-106.
8. Edmeads J, Findlay H, Tugwell P et al. Impact of Migraine and Tension-Type Headache on Life-Style, Consulting Behaviour, and Medication Use: A Canadian Population Survey. Can J Neurol Sci 1993; 20: 131-7.
9. Rasmussen BK, Jensen R, Olesen J. A population-based analysis of the diagnostic criteria of the International Headache Society. Cephalalgia 1991; 11: 129-34.
10. Rasmussen BK, Jensen R, Olesen J. Impact of Headache on Sickness Absence and Utilisation of Medical Services. A Danish Population Study. J Epidemiol Community Health 1992; 46: 443-6.
11. Nikoforow R, Hokkanen E. Effects of headache on working ability: A survey of an urban and a rural population in Northern Finland. Headache 1979; 19: 214-18.
12. Silberstein SD, Lipton RB, Solomon S et al. Classification of daily and near daily headache: proposed revisions to the IHS criteria. Headache 1994; 34: 1-7.
13. Pöllmann W, Keidel M, Pfaffenrath V. Kopfschmerzen und die Halswirbelsäule. Nervenarzt 1996; 67: 821-36.
14. Schnider P, Aull S, Feucht M et al. Use and abuse of analgesics in tension-type headache. Cephalalgia 1994; 14: 162-7.
15. Diener H-C, Dichgans J, Scholz E et al. Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 1989; 235: 9-14.
16. Jensen R, Rasmussen BK, Pedersen B et al. Muscle tenderness and pressure pain thresholds in headache. A population study. Pain 1993; 52: 193-9.
17. Langemark M, Bach FW, Jensen TS et al. Decreased nociceptive flexion reflex threshold in chronic tension-type headache. Arch Neurol 1993; 50: 1061-4.
18. Schoenen J, Wolff Award 1992. Exteroceptive suppression of temporalis muscle activity in patients with chronic headache and in normal volunteers: methodology, clinical and pathophysiological relevance. Headache 1993; 33: 3-17.
19. Olesen J. Clinical and pathophysiologial observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofascial inputs. Pain 1991; 46: 125-32.
20. Diamond S. Depression and headache. Headache 1983; 23: 122-6.
21. Rolf LH, Wiele G, Brune GG. 5-Hydroxytryptamine in platelets of patients with muscle contraction headache. Headache 1981; 21: 10-11.
22. Anthony M, Lance JW. Platelet serotonin in patients with chronic tension-type headache. J Neurol Neurosurg Psychiatry 1989; 52: 182-4.
23. Ferrari MD. Biochemistry. In: Olesen J, Tfelft-Hansen P, Welch KMA, (eds). The headaches. New York: Raven Press 1993; 455-61.
24. Soyka D. Schmerztherapie mit Psychopharmaka. Nervenheilkunde 1996; 15: 50-5.
25. Sharav Y, Singer E, Schmidt E et al. The analgetic effect of amitriptyline on chronic facial pain. Pain 1987; 31: 199-209.
26. Panerai AE, Monza G, Movilia P et al. A randomized, within-patient, crossover, placebo-controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain. Acta Neurol Sand 1990; 82: 34-8.
27. Egbunike IG, Chaffee BJ. Antidepressants in the management of chronic pain syndrome. Pharmacotherapy 1990; 10: 262-70.
28. Onghena P, Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 1992; 49: 205-19.
29. Botney M, Fields HL. Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann Neurol 1983; 13: 160-4.
30. Tollison CD, Krigel ML. Selected tricyclic antidepressants in the management of chronic benign pain. South Med J 1988; 81: 562-4.
31. Tura B, Tura SM. The analgesic effect of tricyclic antidepressants. Brain Res 1990; 518: 19-22.
32. Sacerdote P, Brini A, Mantegazza P, Panerai AE. A role for serotonin and beta-endorphin in the analgesia induced by some trycyclic antidepressant drugs. Pharmacol Biochem Behav 1987; 26: 153-8.
33. Ardid D, Marty H, Fialip J et al. Comparative effects of different uptake inhibitor antidepressants in two pain tests in mice. Fundam Clin Pharmacol 1992; 6: 75-82.
34. Watson CP, Evans RJ. A comparative trial of amitriptyline and zimelidine in post-herpetic neuralgia. Pain 1985; 23: 387-94.
35. Sindrup SH, Gram LF, Brosen K et al. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990; 42: 135-44.
36. Bendtsen L, Jensen R, Olesen J. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. Journal of Neurol, Neurosurg and Psych 1996; 61: 285-90.
37. Hyttel J. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171. Psychopharmacology 1977; 51: 225-33.
38. Taiwo YO, Fabian A, Pazoles CJ, Fields HL. Potentiation of morphine antinociception by monoamine reuptake inhibitors in the rat spinal cord. Pain 1985; 21: 329-37.
39. Hyttel J. Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 1982; 6: 277-95.
40. U'Prichard DC, Greenberg DA, Sheeman PP, Snyder SH. Tricyclic antidepressants: therapeutic properties and affinity for alpha-noradrenergic receptor binding sites in the brain. Science 1978; 199: 197-9.
41. Sindrup SH, Gram LF, Skjold T. Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. Br J Clin Pharmacol 1990; 30: 683-91.
42. Glaum SR, Proudfit HK, Anderson EG. Reversal of the antinociceptice effects of intrathecally administered serotonin in the rat by a selective 5-HT-3 receptor antagonist. Neurosci Lett 1988; 95: 313-7.
43. Diener HC, Edmeads J. Tension type headache. General approach to treatment. In: "The Headaches" edited by J. Olesen, P. Tfelt-Hansen and KMA Welch. New York Raven Press. Ltd. 1993; 513-4.
44. Langemark M, Olesen J. Effervescent ASA versus solid ASA in the treatment of tension headache. A double-blind, placebo controlled study. Headache 1987; 27: 90-5.
45. Diamond S. Ibuprofen versus acetylsalicylic acid and placebo in the treatment of muscle contraction headache. Headache 1983; 23: 206-10.
46. Mathew NT. Tension type headache. Acute pharmacotherapy. In: "The Headaches". J. Olesen, P. Tfelt-Hansen and KMA (eds). Welch New York. Raven Press, Ltd. 1993; 531-6.
47. Schachtel BP, Thoden WR. Onset of action of ibuprofen in the treatment of muscle-contraction headache. Headache 1988; 28: 471-4.
48. Göbel H, Heinze A, Dworschak M et al. Oleum menthae piperitae significantly reduces the symptoms of tension-type headache and its efficacy does not differ from that of acetaminophen. In: "Headache Treatment: Trial Methodology and New Drugs", J. Olesen and P. Tfelt-Hansen (eds). Philadelphia Lippincott-Raven Publishers 1997.
49. Lance JW, Curran DA. Treatment of chronic tension headache. Lancet 1964; 1: 1235-9.
50. Diamond S, Baltes BJ. Chronic tension headache treated with amitriptyline: a double-blind study. Headache 1971; 11: 110-6.
51. Pfaffenrath V, Diener HC, Isler H et al. Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multi-centre controlled study. Cephalalgia 1994; 14: 149-55.
52. Couch JR, Ziegler DK, Hassanein R. Amitriptyline in the prophylaxis of migraine. Neurology 1976; 26: 121-7.
53. Mathew NT. Prophylaxis of migraine and mixed headache. A randomized controlled study. Headache 1981; 21: 105-9.
54. Ziegler DK, Hurwitz A, Preskorn S et al. Propranolol and amitriptyline in prophylaxis of migraine: pharmacokinetic and therapeutic effects. Arch Neurol 1993; 50: 825-30.
55. Carasso RL, Yehuda S, Streifler M. Clomipramine and amitriptyline in the treatment of severe pain. Int J Neurosci 1979; 9: 191-4.
56. Morland T, Storli OV, Mogstad T-E. Doxepin in the prophylactic treatment of mixed 'vascular' and tension headache. Headache 1979; 19: 382-3.
57. Langemark M, Loldrup D, Bech P et al. Clomipramine and mianserin in the treatment of chronic tension headache. A double-blind, controlled study. Headache 1990; 10: 118-21.
58. Denaro A, Martucci N, Ruggieri S et al. Headache and noradrenergic involvement: the effects of alpha-2 stimulants and alpha-2-antagonists. Acta Psychiatr Scand 1985; 72: 20-5.
59. Fogelhom R, Murros K. Maprotiline in chronic tension headache: a double-blind cross-over study. Headache 1985; 25: 273-5.
60. Nappe G, Sandrini G, Granella F et al. A new 5-HT2 antagonist (Ritanserin) in the treatment of chronic Headache with depression. A double blind study vs. amitriptyline. Headache 1990; 30: 439-44.
61. Langemark M, Olesen J. Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial. Headache 1994; 34: 20-4.
62. Saper J, Silberstein S, Lake A. Double blind trials of fluoxetine: chronic daily headache and migraine. Headache 1993; 33: 266-7.
63. Manna V, Bolino F, Di Cicco L. Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache 1994; 34: 44-9.
64. Palmer KJ, Benfield P. Fluvoxamine: an overview of its pharmacological properties and a review of its use in non-depressive disorders. CNS Drugs 1994; 1: 57-87.
65. Lance JW, Anthony M. Cyclobenzaprine in the treatment of chronic tension headache. Med J Aust 1972; 2: 1409-11.
66. Fogelholm R, Murros K. Tizanidine in chronic tension-type headache: a placebo-controlled double-blind cross-over study. Headache 1992; 32: 509-13.
67. Mathew NT, Ali S. Valproate in the treatment of persistent chronic daily headache. An open label study. Headache 1991; 31: 71-4.
68. Rothrock JF, Kelly NM, Brody ML et al. A differential response to treatment with divalproex sodium in patients with intractable headache. Cephalalgia 1994; 14: 241-4.
69. Freitag FG, Diamond S, Solomon GD. Antidepressants in the treatment of mixed headache: MAO inhibitors and combined use of MAO inhibitors and tricyclic antidepressants in the recidivist headache patient. In: Clifford Rose F (ed). Advances in headache research. London: John Libbey 1987; 271-5.
70. Pfaffenrath V, Gerber WD. Chronische Kopfschmerzen. Stuttgart, Kohlhammer Verlag 1992.
71. Basler HD, Franz C, Körner-Herwig B et al. (Hrsg). Psychologische Schmerztherapie. Heidelberg, Springer 1996.
72. Holroyd KA. Psychological and behavioural techniques. In: Olesen J, Tfelt-Hansen P, Welche KMA (eds). The headaches. New York: Raven Press 1993; 515-20.